Current and historical daily PE Ratio for Quest Diagnostics Inc (
) from 1996 to Apr 27 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Quest Diagnostics stock (DGX) PE ratio as of Apr 27 2024 is 18.07.
More Details
Quest Diagnostics Inc (DGX) PE Ratio (TTM) Chart
Quest Diagnostics Inc (DGX) PE Ratio (TTM) Historical Data
View and export this data going back to 1996. Start your Free Trial
Total 1217
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Quest Diagnostics PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-27 | 18.1 | 2024-02-23 | 17.0 |
| 2024-04-26 | 18.1 | 2024-02-22 | 16.7 |
| 2024-04-25 | 18.2 | 2024-02-21 | 16.9 |
| 2024-04-24 | 18.5 | 2024-02-20 | 16.5 |
| 2024-04-23 | 18.4 | 2024-02-16 | 16.6 |
| 2024-04-22 | 17.5 | 2024-02-15 | 16.8 |
| 2024-04-19 | 17.3 | 2024-02-14 | 17.1 |
| 2024-04-18 | 16.9 | 2024-02-13 | 17.1 |
| 2024-04-17 | 17.1 | 2024-02-12 | 17.4 |
| 2024-04-16 | 17.1 | 2024-02-09 | 16.9 |
| 2024-04-15 | 17.3 | 2024-02-08 | 16.9 |
| 2024-04-12 | 17.3 | 2024-02-07 | 17.0 |
| 2024-04-11 | 17.5 | 2024-02-06 | 16.9 |
| 2024-04-10 | 17.7 | 2024-02-05 | 16.5 |
| 2024-04-09 | 17.9 | 2024-02-02 | 16.7 |
| 2024-04-08 | 17.5 | 2024-02-01 | 17.0 |
| 2024-04-05 | 17.6 | 2024-01-31 | 17.1 |
| 2024-04-04 | 17.7 | 2024-01-30 | 17.2 |
| 2024-04-03 | 17.8 | 2024-01-29 | 17.3 |
| 2024-04-02 | 17.8 | 2024-01-26 | 17.4 |
| 2024-04-01 | 18.1 | 2024-01-25 | 17.4 |
| 2024-03-28 | 17.9 | 2024-01-24 | 17.1 |
| 2024-03-27 | 17.5 | 2024-01-23 | 17.3 |
| 2024-03-26 | 17.2 | 2024-01-22 | 17.4 |
| 2024-03-25 | 17.3 | 2024-01-19 | 17.7 |
| 2024-03-22 | 17.3 | 2024-01-18 | 17.9 |
| 2024-03-21 | 17.2 | 2024-01-17 | 17.9 |
| 2024-03-20 | 17.1 | 2024-01-16 | 17.9 |
| 2024-03-19 | 17.2 | 2024-01-12 | 18.1 |
| 2024-03-18 | 17.1 | 2024-01-11 | 18.1 |
| 2024-03-15 | 17.1 | 2024-01-10 | 18.3 |
| 2024-03-14 | 17.0 | 2024-01-09 | 19.0 |
| 2024-03-13 | 17.3 | 2024-01-08 | 18.9 |
| 2024-03-12 | 17.3 | 2024-01-05 | 19.0 |
| 2024-03-11 | 17.3 | 2024-01-04 | 18.8 |
| 2024-03-08 | 17.0 | 2024-01-03 | 18.6 |
| 2024-03-07 | 17.0 | 2024-01-02 | 18.8 |
| 2024-03-06 | 16.9 | 2023-12-29 | 18.4 |
| 2024-03-05 | 16.6 | 2023-12-28 | 18.4 |
| 2024-03-04 | 16.7 | 2023-12-27 | 20.7 |
| 2024-03-01 | 16.6 | 2023-12-26 | 20.5 |
| 2024-02-29 | 16.7 | 2023-12-22 | 20.5 |
| 2024-02-28 | 16.8 | 2023-12-21 | 20.4 |
| 2024-02-27 | 16.9 | 2023-12-20 | 20.2 |
| 2024-02-26 | 16.9 | 2023-12-19 | 20.5 |
Quest Diagnostics Inc (DGX) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Quest Diagnostics Inc
NAICS : 621511
SIC : 8071
ISIN : US74834L1008
Share Class Description:
DGX: Ordinary SharesDescription
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers